KYKeejung Yoon

Keejung Yoon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Keejung Yoon has a total of 182 co-authors. Here are the top co-authors by number of shared publications:

  • Mookwang Kwon

    Affiliation College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, South Korea

    11 shared publications
  • Dasol Han

    Affiliation College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, South Korea

    8 shared publications
  • Juwan Kim

    College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, South Korea

    6 shared publications
  • Sung-Hyun Byun

    College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, Gyeonggi-Do, Republic of Korea

    5 shared publications
  • Jae Youl Cho

    Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Suwon 16419, Gyeonggi Do, South Korea

    4 shared publications
  • Jiwon Jang

    Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea

    4 shared publications

Latest Publications

  • Open Access

    BBX maintains mammalian brain development by repressing p53-mediated p21 expression

    by Youngik Yoon, Gwang Yeong Kim, Woo Young Lim, Saeah Hwang, Solji Lee, Dongrok Yoon, Samuel J Pleasure, Keejung Yoon

    Brain development requires coordinated regulation of neural stem cell (NSC) proliferation, differentiation, and neuronal migration. Here, we identify bobby sox homolog (BBX), a nuclear HMG box domain-containing protein enriched in mouse embryonic cortical germinal zones, as a regulator of corticogenesis. In the embryonic cortex, BBX depletion reduces SOX2-expressing NSCs, promotes premature cell-cycle exit, disrupts cortical cell positioning, causes abnormal clustering of newborn neurons, and impairs migratory neuron morphology. RNA-seq and public ChIP-seq analyses, together with biochemical assays, show that BBX interacts with p53 and suppresses p53-dependent p21 expression. Consistent with activation of the p21 pathway, BBX knockdown increases premature cell-cycle exit and senescence-associated features, including γH2AX accumulation and senescence-associated gene expression. Co-depletion of p21 rescues BBX knockdown-induced defects in NSC maintenance, neuronal distribution, and morphology. In line with this, depletion of retinoblastoma protein (RB), a major mediator of p21-dependent senescence, restores abnormal cortical cell distribution. These findings indicate that BBX maintains normal cortical development by restraining the p53–p21–RB axis, thereby preventing premature cell-cycle exit and senescence in developing neural cells.

  • Open Access

    Verteporfin is an effective inhibitor of HCMV replication

    by Woo Young Lim, Ju Hyun Lee, Youngju Choi, Keejung Yoon


  • STAC1 is required for glioblastoma cell invasion and survival

    by Youngik Yoon, Chae Rin Yoo, Eun Chae Kim, Jaehwan Han, Keejung Yoon


  • Open Access

    YAP inhibits HCMV replication by impairing STING-mediated nuclear transport of the viral genome

    by Ju Hyun Lee, Mookwang Kwon, Woo Young Lim, Chae Rin Yoo, Youngik Yoon, Dasol Han, Jin-Hyun Ahn, Keejung Yoon

    YES-associated protein (YAP), a critical actor of the mammalian Hippo signaling pathway involved in diverse biological events, has gained increased recognition as a cellular factor regulated by viral infections, but very few studies have investigated their relationship vice versa. In this study, we show that YAP impairs HCMV replication as assessed by viral gene expression analysis and progeny assays, and that this inhibition occurs at the immediate-early stages of the viral life cycle, at the latest. Using YAP mutants lacking key functional domains and shRNA against TEAD, we show that the inhibitory effects of YAP on HCMV replication are nuclear localization- and TEAD cofactor-dependent. Quantitative real-time PCR (qPCR) and subcellular fractionation analyses reveal that YAP does not interfere with the viral entry process but inhibits transport of the HCMV genome into the nucleus. Most importantly, we show that the expression of stimulator of interferon genes (STING), recently identified as an important component for nuclear delivery of the herpesvirus genome, is severely downregulated by YAP at the level of gene transcription. The functional importance of STING is further confirmed by the observation that STING expression restores YAP-attenuated nuclear transport of the HCMV genome, viral gene expression, and progeny virus production. We also show that HCMV-upregulated YAP reduces expression of STING. Taken together, these findings indicate that YAP possesses both direct and indirect regulatory roles in HCMV replication at different infection stages.


  • The CRHR1/CREB/REST signaling cascade regulates mammalian embryonic neural stem cell properties

    by Mookwang Kwon, Ju Hyun Lee, Youngik Yoon, Samuel J Pleasure, Keejung Yoon

    Growing evidence suggests that the corticotropin-releasing hormone (CRH) signaling pathway, mainly known as a critical initiator of humoral stress responses, has a role in normal neuronal physiology. However, despite the evidence of CRH receptor (CRHR) expression in the embryonic ventricular zone, the exact functions of CRH signaling in embryonic brain development have not yet been fully determined. In this study, we show that CRHR1 is required for the maintenance of neural stem cell properties, as assessed by in vitro neurosphere assays and cell distribution in the embryonic cortical layers following in utero electroporation. Identifying the underlying molecular mechanisms of CRHR1 action, we find that CRHR1 functions are accomplished through the increasing expression of the master transcription factor REST. Furthermore, luciferase reporter and chromatin immunoprecipitation assays reveal that CRHR1-induced CREB activity is responsible for increased REST expression at the transcriptional level. Taken together, these findings indicate that the CRHR1/CREB/REST signaling cascade plays an important role downstream of CRH in the regulation of neural stem cells during embryonic brain development.


  • Gamma secretase inhibition impairs HCMV replication by reduction of immediate early gene expression at the transcriptional level

    by Sun Min Lee, Dasol Han, Mookwang Kwon, Hogyun Noh, Ju Hyun Lee, Youngik Yoon, Jae Youl Cho, Jin-Hyun Ahn, Keejung Yoon


  • Open Access

    Water Extract of Lotus Leaf Alleviates Dexamethasone-Induced Muscle Atrophy via Regulating Protein Metabolism-Related Pathways in Mice

    by Sang Hee Park, Jieun Oh, Minkyeong Jo, Jin Kyeong Kim, Dong Seon Kim, Han Gyung Kim, Keejung Yoon, Yoonyong Yang, Jeong-Ho Geum, Jung-Eun Kim, et al.

    Muscle atrophy is an abnormal condition characterized by loss of skeletal muscle mass and function and is primarily caused by injury, malnutrition, various diseases, and aging. Leaf of lotus (Nelumbo nucifera Gaertn), which has been used for medicinal purposes, contains various active ingredients, including polyphenols, and is reported to exert an antioxidant effect. In this study, we investigated the effect of water extract of lotus leaf (LL) on muscle atrophy and the underlying molecular mechanisms of action. Amounts of 100, 200, or 300 mg/kg/day LL were administered to dexamethasone (DEX)-induced muscle atrophy mice for 4 weeks. Micro-computed tomography (CT) analysis revealed that the intake of LL significantly increased calf muscle volume, surface area, and density in DEX-induced muscle atrophy mice. Administration of LL recovered moving distance, grip strength, ATP production, and body weight, which were decreased by DEX. In addition, muscle damage caused by DEX was also improved by LL. LL reduced the protein catabolic pathway by suppressing gene expression of muscle atrophy F-Box (MAFbx; atrogin-1), muscle RING finger 1 (MuRF1), and forkhead box O (FoxO)3a, as well as phosphorylation of AMP-activated kinase (AMPK). The AKT-mammalian target of the rapamycin (mTOR) signal pathway, which is important for muscle protein synthesis, was increased in LL-administered groups. The HPLC analysis and pharmacological test revealed that quercetin 3-O-beta-glucuronide (Q3G) is a major active component in LL. Thus, Q3G decreased the gene expression of atrogin-1 and MuRF1 and phosphorylation of AMPK. This compound also increased phosphorylation levels of mTOR and its upstream enzyme AKT in DEX-treated C2C12 cells. We identified that LL improves muscle wasting through regulation of muscle protein metabolism in DEX-induced muscle atrophy mice. Q3G is predicted to be one of the major active phenolic components in LL. Therefore, we propose LL as a supplement or therapeutic agent to prevent or treat muscle wasting, such as sarcopenia.


  • Open Access

    Non-cell autonomous promotion of astrogenesis at late embryonic stages by constitutive YAP activation

    by Dasol Han, Mookwang Kwon, Sun Min Lee, Samuel J. Pleasure, Keejung Yoon

    Although astrocytes have gained increased recognition as an important regulator in normal brain function and pathology, the mechanisms underlying their genesis are not well understood. In this study, we show that constitutive YAP activation by in utero introduction of a non-degradable form of the YAP gene (YAP 5SA) causes productive GFAP+ cell generation at late embryonic periods, and this activity is nuclear localization- and TEAD transcription factor-dependent. Moreover, we found that the GFAP+ cells were not YAP 5SA-expressing cells themselves but cells in the vicinity in vivo. Conditioned medium prepared from YAP 5SA-expressing cells induced GFAP+ cell production in vitro, suggesting that a soluble factor(s) was mediating the astrogenic activity of YAP 5SA. Indeed, YAP 5SA expression greatly increased CNTF and BMP4 transcription in neural progenitor cells, and a neutralizing antibody against CNTF reduced the astrogenic effects of YAP 5SA-conditioned medium. Furthermore, the YAP 5SA-expressing cells were identified as FN1+ mesenchymal cells which are responsible for the precocious astrogenesis. These results suggest a novel molecular mechanism by which YAP activation can induce astrogenesis in a non-cell autonomous manner.


  • Open Access

    Protein Arginine Methyltransferase 1 (PRMT1) Selective Inhibitor, TC-E 5003, Has Anti-Inflammatory Properties in TLR4 Signaling

    by Eunji Kim, Jiwon Jang, Jae Gwang Park, Kyung-Hee Kim, Keejung Yoon, Byong Chul Yoo, Jae Youl Cho

    Protein arginine methyltransferase 1 (PRMT1) is the most predominant PRMT and is type I, meaning it generates monomethylarginine and asymmetric dimethylarginine. PRMT1 has functions in oxidative stress, inflammation and cancers, and modulates diverse diseases; consequently, numerous trials to develop PRMT1 inhibitors have been attempted. One selective PRMT1 inhibitor is N,N′-(Sulfonyldi-4,1-phenylene)bis(2-chloroacetamide), also named TC-E 5003 (TC-E). In this study, we investigated whether TC-E regulated inflammatory responses. Nitric oxide (NO) production was evaluated by the Griess assay and the inflammatory gene expression was determined by conducting RT-PCR. Western blot analyzing was carried out for inflammatory signaling exploration. TC-E dramatically reduced lipopolysaccharide (LPS)-induced NO production and the expression of inflammatory genes (inducible NO synthase (iNOS), cyclooxygenase (COX)-2, tumor necrosis factor (TNF)-α and interleukin (IL)-6) as determined using RT-PCR. TC-E downregulated the nuclear translocation of the nuclear factor (NF)-κB subunits p65 and p50 and the activator protein (AP)-1 transcriptional factor c-Jun. Additionally, TC-E directly regulated c-Jun gene expression following LPS treatment. In NF-κB signaling, the activation of IκBα and Src was attenuated by TC-E. Taken together, these data show that TC-E modulates the lipopolysaccharide (LPS)-induced AP-1 and NF-κB signaling pathways and could possibly be further developed as an anti-inflammatory compound.